| Julio Cesar Delgado, MD | |
|
500 Chipeta Way, Arup Laboratories, Salt Lake City, UT 84108-1221 | |
| (801) 583-2787 | |
| Not Available |
| Full Name | Julio Cesar Delgado |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 31 Years |
| Location | 500 Chipeta Way, Salt Lake City, Utah |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689621948 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZC0006X | Pathology - Clinical Pathology | 6234516-1205 (Utah) | Secondary |
| 207SM0001X | Medical Genetics - Molecular Genetic Pathology | 6234516-1205 (Utah) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| University Of Utah Hospitals And Clinics | Salt lake city, UT | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| University Of Utah Adult Services | 0941525273 | 1459 |
News Archive
SynCardia Systems, Inc., manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to conduct an Investigational Device Exemption (IDE) clinical study of the Freedom™ driver system, the first-ever U.S. portable driver designed to power SynCardia's Total Artificial Heart.
Royal Philips today released "Sleep: A Global Perspective," the first in a series of reports highlighting sleep trends and habits collected from a survey of nearly 8,000 people across 10 countries.
Researchers have identified a critical new step in how brain cells function in people with one of the most common forms of epilepsy.
BioRx, a national specialty pharmacy and infusion services provider, has been added to the limited distribution network for Zemaira [alpha-1 proteinase inhibitor (human)]. Zemaira is indicated for chronic augmentation and maintenance therapy in individuals with alpha1-antitrypsin (AAT) deficiency and clinical evidence of emphysema.
› Verified 8 days ago
| Entity Name | University Of Utah Adult Services |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114321981 PECOS PAC ID: 0941525273 Enrollment ID: O20150209001683 |
News Archive
SynCardia Systems, Inc., manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to conduct an Investigational Device Exemption (IDE) clinical study of the Freedom™ driver system, the first-ever U.S. portable driver designed to power SynCardia's Total Artificial Heart.
Royal Philips today released "Sleep: A Global Perspective," the first in a series of reports highlighting sleep trends and habits collected from a survey of nearly 8,000 people across 10 countries.
Researchers have identified a critical new step in how brain cells function in people with one of the most common forms of epilepsy.
BioRx, a national specialty pharmacy and infusion services provider, has been added to the limited distribution network for Zemaira [alpha-1 proteinase inhibitor (human)]. Zemaira is indicated for chronic augmentation and maintenance therapy in individuals with alpha1-antitrypsin (AAT) deficiency and clinical evidence of emphysema.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Julio Cesar Delgado, MD 500 S Chipeta Way, Arup Laboratories, Salt Lake City, UT 84108-1221 Ph: (801) 583-2787 | Julio Cesar Delgado, MD 500 Chipeta Way, Arup Laboratories, Salt Lake City, UT 84108-1221 Ph: (801) 583-2787 |
News Archive
SynCardia Systems, Inc., manufacturer of the SynCardia temporary CardioWest™ Total Artificial Heart, today announced it has received conditional approval from the U.S. Food and Drug Administration (FDA) to conduct an Investigational Device Exemption (IDE) clinical study of the Freedom™ driver system, the first-ever U.S. portable driver designed to power SynCardia's Total Artificial Heart.
Royal Philips today released "Sleep: A Global Perspective," the first in a series of reports highlighting sleep trends and habits collected from a survey of nearly 8,000 people across 10 countries.
Researchers have identified a critical new step in how brain cells function in people with one of the most common forms of epilepsy.
BioRx, a national specialty pharmacy and infusion services provider, has been added to the limited distribution network for Zemaira [alpha-1 proteinase inhibitor (human)]. Zemaira is indicated for chronic augmentation and maintenance therapy in individuals with alpha1-antitrypsin (AAT) deficiency and clinical evidence of emphysema.
› Verified 8 days ago